The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Dermagraft-TC has been approved as a temporary wound covering
for partial-thickness burns. Dermagraft-TC was first approved for
marketing in March, 1997 as a temporary wound covering for severe
burns. Dermagraft-TC is the first human, fibroblast-derived
temporary skin substitute for the treatment of partial-thickness
burns that has been approved for marketing by the FDA.
Partial-thickness burns, or second degree burns, are those in
which there is damage to the epidermis (the upper layer of the
skin) and the upper portion of the dermis (the lower layer of
skin). However, a portion of the dermis remains intact.
Partial-thickness burns are the most common type of burn injury
requiring medical attention. These burns frequently result from
household hazards such as scalding from hot liquids, faulty heating
pads or misuse of ignition fluids.